Literature DB >> 8698851

Activation of antigen-induced lymphocyte proliferation by interleukin-15 without the mitogenic effect of interleukin-2 that may induce human immunodeficiency virus-1 expression.

A H Patki1, M E Quiñones-Mateu, D Dorazio, B Yen-Lieberman, W H Boom, E K Thomas, M M Lederman.   

Abstract

The newly identified cytokine, IL-15 enhanced antigen-induced proliferation of PBMC obtained from HIV-1-seropositive subjects. When compared to IL-2 which enhanced both spontaneous and antigen-induced lymphocyte proliferative responses, IL-15 rarely increased spontaneous lymphocyte proliferation. Additionally, in cultures of lymphocytes obtained from 15 HIV-1-infected patients with < 300 circulating CD4- lymphocytes/microliter IL-15 induced significant HIV-1 expression (46, 21, and 71 pg/ml) in only 3 of 15 experiments and IL-2 induced significant HIV-1 expression (range 16- > 5000 pg/ml) in 11 of 15 experiments (P < 0.01, Fischer's exact test). Simultaneous assays of cytokine-induced spontaneous lymphocyte proliferation and HIV-1 expression revealed similar dose-response relationships for induction of HIV-1 and lymphocyte proliferation by IL-2. Thus, IL-15 helps to correct the impaired proliferative response of CD4+ lymphocytes from HIV-1-infected persons without the mitogenic effect of IL-2 that also may induce HIV-1 expression.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8698851      PMCID: PMC507469          DOI: 10.1172/JCI118831

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  12 in total

1.  Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition.

Authors:  H C Lane; J M Depper; W C Greene; G Whalen; T A Waldmann; A S Fauci
Journal:  N Engl J Med       Date:  1985-07-11       Impact factor: 91.245

2.  Selective loss of T cell functions in different stages of HIV infection. Early loss of anti-CD3-induced T cell proliferation followed by decreased anti-CD3-induced cytotoxic T lymphocyte generation in AIDS-related complex and AIDS.

Authors:  R A Gruters; F G Terpstra; R De Jong; C J Van Noesel; R A Van Lier; F Miedema
Journal:  Eur J Immunol       Date:  1990-05       Impact factor: 5.532

3.  Interleukin 2 induces CD8+ T cell-mediated suppression of human immunodeficiency virus replication in CD4+ T cells and this effect overrides its ability to stimulate virus expression.

Authors:  A L Kinter; S M Bende; E C Hardy; R Jackson; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

4.  Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study.

Authors:  J A Kovacs; M Baseler; R J Dewar; S Vogel; R T Davey; J Falloon; M A Polis; R E Walker; R Stevens; N P Salzman; Lane H. Clifford
Journal:  N Engl J Med       Date:  1995-03-02       Impact factor: 91.245

5.  Elevated IFN-gamma and decreased IL-2 gene expression are associated with HIV infection.

Authors:  J Fan; H Z Bass; J L Fahey
Journal:  J Immunol       Date:  1993-11-01       Impact factor: 5.422

6.  Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor.

Authors:  K H Grabstein; J Eisenman; K Shanebeck; C Rauch; S Srinivasan; V Fung; C Beers; J Richardson; M A Schoenborn; M Ahdieh
Journal:  Science       Date:  1994-05-13       Impact factor: 47.728

7.  Heterogeneous effects of exogenous IL-2 on HIV-specific cell-mediated immunity (CMI).

Authors:  S J Bell; D A Cooper; B E Kemp; R R Doherty; R Penny
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

8.  A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS).

Authors:  G M Shearer; D C Bernstein; K S Tung; C S Via; R Redfield; S Z Salahuddin; R C Gallo
Journal:  J Immunol       Date:  1986-10-15       Impact factor: 5.422

9.  Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome.

Authors:  A H Rook; H Masur; H C Lane; W Frederick; T Kasahara; A M Macher; J Y Djeu; J F Manischewitz; L Jackson; A S Fauci; G V Quinnan
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

10.  Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs.

Authors:  F Miedema; A J Petit; F G Terpstra; J K Schattenkerk; F de Wolf; B J Al; M Roos; J M Lange; S A Danner; J Goudsmit
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

View more
  11 in total

1.  Induction of HIV-1 replication by type 1-like cytokines, interleukin (IL)-12 and IL-15: effect on viral transcriptional activation, cellular proliferation, and endogenous cytokine production.

Authors:  L Al-Harthi; K A Roebuck; A Landay
Journal:  J Clin Immunol       Date:  1998-03       Impact factor: 8.317

2.  Interleukin-15 increases effector memory CD8+ t cells and NK Cells in simian immunodeficiency virus-infected macaques.

Authors:  Yvonne M Mueller; Constantinos Petrovas; Paul M Bojczuk; Ioannis D Dimitriou; Brigitte Beer; Peter Silvera; Francois Villinger; J Scott Cairns; Edward J Gracely; Mark G Lewis; Peter D Katsikis
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

3.  Isolation of mycobacterium-reactive CD1-restricted T cells from patients with human immunodeficiency virus infection.

Authors:  J Gong; S Stenger; J A Zack; B E Jones; G C Bristol; R L Modlin; P J Morrissey; P F Barnes
Journal:  J Clin Invest       Date:  1998-01-15       Impact factor: 14.808

Review 4.  Antigen-dependent and -independent mechanisms of T and B cell hyperactivation during chronic HIV-1 infection.

Authors:  Anna Haas; Kathrin Zimmermann; Annette Oxenius
Journal:  J Virol       Date:  2011-08-17       Impact factor: 5.103

5.  Effect of interleukin (IL)-12 and IL-15 on activated natural killer (ANK) and antibody-dependent cellular cytotoxicity (ADCC) in HIV infection.

Authors:  S J Lin; R L Roberts; B J Ank; Q H Nguyen; E K Thomas; E R Stiehm
Journal:  J Clin Immunol       Date:  1998-09       Impact factor: 8.317

6.  Interleukin-15 production by monocyte-derived dendritic cells and T cell proliferation in HIV-infected patients with discordant response to highly active antiretroviral therapy.

Authors:  G d'Ettorre; G Forcina; M Andreotti; L Sarmati; L Palmisano; M Andreoni; S Vella; C M Mastroianni; V Vullo
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

7.  IL-15 treatment during acute simian immunodeficiency virus (SIV) infection increases viral set point and accelerates disease progression despite the induction of stronger SIV-specific CD8+ T cell responses.

Authors:  Yvonne M Mueller; Duc H Do; Susan R Altork; Carol M Artlett; Edward J Gracely; Christos D Katsetos; Agustin Legido; Francois Villinger; John D Altman; Charles R Brown; Mark G Lewis; Peter D Katsikis
Journal:  J Immunol       Date:  2008-01-01       Impact factor: 5.422

8.  Studies on the production of IL-15 in HIV-infected/AIDS patients.

Authors:  Rasheed Ahmad; Sardar T A Sindhu; Emil Toma; Richard Morisset; Ali Ahmad
Journal:  J Clin Immunol       Date:  2003-03       Impact factor: 8.317

9.  Increased IL-15 production is associated with higher susceptibility of memory CD4 T cells to simian immunodeficiency virus during acute infection.

Authors:  Matthew D Eberly; Muhamuda Kader; Wail Hassan; Kenneth A Rogers; Jianzhong Zhou; Yvonne M Mueller; Mary J Mattapallil; Michael Piatak; Jeffrey D Lifson; Peter D Katsikis; Mario Roederer; Francois Villinger; Joseph J Mattapallil
Journal:  J Immunol       Date:  2009-02-01       Impact factor: 5.422

10.  Cytomegalovirus infection in Gambian infants leads to profound CD8 T-cell differentiation.

Authors:  David J C Miles; Marianne van der Sande; David Jeffries; Steve Kaye; Jamila Ismaili; Olubukola Ojuola; Mariama Sanneh; Ebrima S Touray; Pauline Waight; Sarah Rowland-Jones; Hilton Whittle; Arnaud Marchant
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.